SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Trends in development and approval times for new therapeutics in the United States
0 references·4 citing·20 second hop
Trends in development and approval times for new therapeutics in the United States (2003)Trends in development and approval times …How do patent-based measures inform product commercialization? —The case of the United States pharmaceutical industry (2018)How do patent-based measures …An Empirical Review of Major Legislation Affecting Drug Development: Past Experiences, Effects, and Unintended Consequences (2011)An Empirical Review of Major …Are Development Times For Pharmaceuticals Increasing Or Decreasing? (2006)Are Development Times For Pha…Science, pharmacoeconomics and ethics in drug R&D: a sustainable future scenario? (2004)Science, pharmacoeconomics an…Can Patents Deter Innovation? The Anticommons in Biomedical Research (1998)Universities as a Source of Commercial Technology: A Detailed Analysis of University Patenting, 1965–1988 (1998)The growth of patenting and licensing by U.S. universities: an assessment of the effects of the Bayh–Dole act of 1980 (2001)The Prevalence and Cost of Unapproved Uses of Top-Selling Orphan Drugs (2012)Towards a sustainable system of drug development (2014)Evaluating The Impact Of The Orphan Drug Act’s Seven-Year Market Exclusivity Period (2018)New drug development in the United States from 1963 to 1999 (2001)Risks in new drug development: Approval success rates for investigational drugs (2001)The price of innovation: new estimates of drug development costs (2003)Pharmaceutical Economics and Policy (1998)Strategic Pricing of New Pharmaceuticals (1998)Estimated research and development costs of rotavirus vaccines (2009)The Use of Flexible Manufacturing Capacity in Pharmaceutical Product Introductions* (2009)Medicare Spending on Brand-name Combination Medications vs Their Generic Constituents (2018)Absorptive Capacity: A New Perspective on Learning and Innovation (1990)Exploration and Exploitation in Organizational Learning (1991)Diffusion of Innovations 1 (2019)R&D spending and patents: levers of national development (2021)Converting inventions into innovations to address cancer grand challenges: The role of scientific and digital search intensity (2023)Psychedelic Commercialization: A Wide-Spanning Overview of the Emerging Psychedelic Industry (2023)
this work references cited by second hop

References

No references inside the corpus for this window.

Cited by

  • 2011An Empirical Review of Major Legislation Affecting Drug Development: Past Experiences, Effects, and Unintended Consequences62 cited
  • 2006Are Development Times For Pharmaceuticals Increasing Or Decreasing?54 cited
  • 2004Science, pharmacoeconomics and ethics in drug R&D: a sustainable future scenario?50 cited
  • 2018How do patent-based measures inform product commercialization? —The case of the United States pharmaceutical industry29 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work